159 related articles for article (PubMed ID: 11256588)
1. DNA microarray technology and antimicrobial drug discovery.
Ivanov I; Schaab C; Planitzer S; Teichmann U; Machl A; Theml S; Meier-Ewert S; Seizinger B; Loferer H
Pharmacogenomics; 2000 May; 1(2):169-78. PubMed ID: 11256588
[TBL] [Abstract][Full Text] [Related]
2. Delivering novel targets and antibiotics from genomics.
Payne DJ; Holmes DJ; Rosenberg M
Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
[TBL] [Abstract][Full Text] [Related]
3. Using genomics to develop novel antibacterial therapeutics.
Nagaraj NS; Singh OV
Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
[TBL] [Abstract][Full Text] [Related]
4. Advances in pharmacogenomics technologies.
Bhasker CR; Hardiman G
Pharmacogenomics; 2010 Apr; 11(4):481-5. PubMed ID: 20350126
[TBL] [Abstract][Full Text] [Related]
5. Novel targets for the future development of antibacterial agents.
McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
[TBL] [Abstract][Full Text] [Related]
6. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
7. Bacterial identification and subtyping using DNA microarray and DNA sequencing.
Al-Khaldi SF; Mossoba MM; Allard MM; Lienau EK; Brown ED
Methods Mol Biol; 2012; 881():73-95. PubMed ID: 22639211
[TBL] [Abstract][Full Text] [Related]
8. The role of genomics in the discovery of novel targets for antibiotic therapy.
Ji Y
Pharmacogenomics; 2002 May; 3(3):315-23. PubMed ID: 12052140
[TBL] [Abstract][Full Text] [Related]
9. Genome medicine promised by microarray technology.
Katsuma S; Tsujimoto G
Expert Rev Mol Diagn; 2001 Nov; 1(4):377-82. PubMed ID: 11901852
[TBL] [Abstract][Full Text] [Related]
10. Genomics technologies and strategies for identification of novel anti-infective agents.
Youngman P; Tepper R; Moore J
Curr Clin Top Infect Dis; 2001; 21():366-90. PubMed ID: 11572160
[No Abstract] [Full Text] [Related]
11. Microarrays in pharmacogenomics--advances and future promise.
Chicurel ME; Dalma-Weiszhausz DD
Pharmacogenomics; 2002 Sep; 3(5):589-601. PubMed ID: 12223046
[TBL] [Abstract][Full Text] [Related]
12. Applications of biochip and microarray systems in pharmacogenomics.
Jain KK
Pharmacogenomics; 2000 Aug; 1(3):289-307. PubMed ID: 11256580
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial drug discovery in the post-genomics era.
Lerner CG; Beutel BA
Curr Drug Targets Infect Disord; 2002 Jun; 2(2):109-19. PubMed ID: 12462143
[TBL] [Abstract][Full Text] [Related]
14. Solexa Ltd.
Bennett S
Pharmacogenomics; 2004 Jun; 5(4):433-8. PubMed ID: 15165179
[TBL] [Abstract][Full Text] [Related]
15. Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
Hardiman G
Pharmacogenomics; 2008 Jan; 9(1):5-9. PubMed ID: 18154443
[No Abstract] [Full Text] [Related]
16. Pharmacogenetics: the Dx perspective.
Cartwright CP
Expert Rev Mol Diagn; 2001 Nov; 1(4):371-6. PubMed ID: 11901851
[TBL] [Abstract][Full Text] [Related]
17. Genomic approaches to antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
[TBL] [Abstract][Full Text] [Related]
18. The application of next-generation sequencing technologies to drug discovery and development.
Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
[TBL] [Abstract][Full Text] [Related]
19. DNA microarrays--techniques and applications in microbial systems.
Majtán T; Bukovská G; Timko J
Folia Microbiol (Praha); 2004; 49(6):635-64. PubMed ID: 15881400
[TBL] [Abstract][Full Text] [Related]
20. Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics.
Gagna CE; Lambert WC
Pharmacogenomics; 2009 May; 10(5):895-914. PubMed ID: 19450135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
